Coya Therapeutics, Inc. COYA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.67M | -21.13M | -21.23M | -18.43M | -20.34M |
| Total Depreciation and Amortization | 19.20K | 23.20K | 27.20K | 27.20K | 27.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.62M | 7.71M | 6.58M | 4.49M | 3.68M |
| Change in Net Operating Assets | -1.69M | -722.00K | 3.88M | 1.77M | 157.50K |
| Cash from Operations | -15.72M | -14.12M | -10.74M | -12.14M | -16.47M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.05M | -2.05M | -1.16M | -516.00K | 0.00 |
| Cash from Investing | -2.05M | -2.05M | -1.16M | -516.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 31.36M | 31.36M | 20.39M | 9.73M | 9.71M |
| Repurchase of Common Stock | -41.80K | -- | -- | -- | -56.30K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -124.30K | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 31.20M | 31.36M | 20.39M | 9.73M | 9.65M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.42M | 15.19M | 8.48M | -2.93M | -6.82M |